Literature DB >> 27165349

Approaches to Inactivate Genes in Zebrafish.

John M Parant1, Jing-Ruey Joanna Yeh2,3.   

Abstract

Animal models of tumor initiation and tumor progression are essential components toward understanding cancer and designing/validating future therapies. Zebrafish is a powerful model for studying tumorigenesis and has been successfully exploited in drug discovery. According to the zebrafish reference genome, 82 % of disease-associated genes in the Online Mendelian Inheritance in Man (OMIM) database have clear zebrafish orthologues. Using a variety of large-scale random mutagenesis methods developed to date, zebrafish can provide a unique opportunity to identify gene mutations that may be associated with cancer predisposition. On the other hand, newer technologies enabling targeted mutagenesis can facilitate reverse cancer genetic studies and open the door for complex genetic analysis of tumorigenesis. In this chapter, we will describe the various technologies for conducting genome editing in zebrafish with special emphasis on the approaches to inactivate genes.

Entities:  

Keywords:  CRISPR; Cancer; Cas9; Gene targeting; Genome engineering; Homologous recombination; Mutagenesis; Transcription activator-like effector nuclease; Zebrafish; Zinc finger nuclease

Mesh:

Year:  2016        PMID: 27165349     DOI: 10.1007/978-3-319-30654-4_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  1 in total

Review 1.  Leveraging the zebrafish to model organ transplantation.

Authors:  Luciana Da Silveira Cavalcante; Mehmet Toner; Korkut Uygun; Shannon N Tessier
Journal:  Curr Opin Organ Transplant       Date:  2019-10       Impact factor: 2.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.